Disparities in Cancer Care

Latest News

health insurance © Kiattisak -adobestock.com
Most Americans Are Not Properly Insured for Surgical Lymphedema Treatment

October 16th 2023

Many Americans with health insurance are not fully covered for frontline procedures to treat lymphedema—a debilitating condition that often affects patients with cancer.

Navigators Prove Crucial in Improving Genomic Testing Rates Among Black Patients With Prostate Cancer
Navigators Prove Crucial in Improving Genomic Testing Rates Among Black Patients With Prostate Cancer

October 13th 2023

paperwork © Chinnapong - stockadobe.com
Administrative Tasks Lead To Skipped Appointments and Unfulfilled Prescriptions in Cancer Care

September 6th 2023

On Average, Hispanic Women Are Younger When They Receive A Breast Cancer Diagnosis
On Average, Hispanic Women Are Younger When They Receive A Breast Cancer Diagnosis

September 5th 2023

© Coetzee/peopleimages.com
Simple Interventions Can Help Oncology Staff Better Communicate With Limited-English Proficiency Patient Populations

August 31st 2023

Video Interviews
Podcasts
The Vitals
The Vitals
Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Updates in Myelodysplastic Syndromes

View More

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

8th Annual School of Nursing Oncology™

Register Now!

Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago

View More

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

More News

© 2023 MJH Life Sciences

All rights reserved.